Andere talen Walvax Biotechnology Co., Ltd.

Aandelen

300142

CNE100000WN2

slotkoers Shenzhen S.E. Andere beurzen 00:00:00 19-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
13,99 ^CNY	-1,89%		-4,77%	-40,49%

07:26	Chinese geneesmiddelenproducenten kunnen mRNA shots niet verkopen, maar geven nog niet op	RE
02/04	Walvax Biotechnology's winst daalt in 2023 met 42%	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

China's drugmakers can't sell mRNA shots but haven't quit yet	07:26
Tranche Update on Walvax Biotechnology Co., Ltd.'s Equity Buyback Plan announced on April 5, 2023.	03/04
Walvax Biotechnology Co., Ltd.'s Equity Buyback announced on April 5, 2023, has expired with 2,000,000 shares, representing 0.12% for CNY 72.2 million.	03/04
Walvax Biotechnology's 2023 Profit Falls 42%	02/04
Walvax Biotechnology Co., Ltd. Proposes Cash Profit Distribution for 2023	01/04
Walvax Biotechnology Scraps Plan to Issue Convertible Bonds	01/04
Walvax Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	26/03
Walvax Biotechnology Sees Up to 45% Drop in 2023 Profit	26/01
Chinese Shares End Mixed as Stimulus Hopes Fade; Walvax Falls 6% on Downbeat Profit Outlook	26/01
Zhifei Biological Falls After Merck Secures Nod to Market HPV Vaccine in China	11/01
Tranche Update on Walvax Biotechnology Co., Ltd.'s Equity Buyback Plan announced on April 5, 2023.	03/01
Lanvin Group Chief Executive Joann Cheng Steps Down	08/12
Walvax Biotechnology Registers Pneumonia Vaccines in Philippines	08/11
Walvax Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25-10-23
Walvax Biotechnology's Unit Gets License to Market Pneumonia Vaccine in Indonesia; Shares Up 3%	24-10-23
Tranche Update on Walvax Biotechnology Co., Ltd.'s Equity Buyback Plan announced on April 5, 2023.	11-10-23
Walvax Biotechnology Unit Gets Nod to Carry Out Vaccine's Phase III Trial in Indonesia	20-09-23
Walvax Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	25-08-23
Walvax Biotechnology's COVID-19 Vaccine Clinical Trial Results Show Efficacy, Safety	11-07-23
Tranche Update on Walvax Biotechnology Co., Ltd.'s Equity Buyback Plan announced on April 5, 2023.	03-07-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Walvax Biotechnology Co., Ltd.

Aandelen

300142

CNE100000WN2

Andere talen

Filters